Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 0.9200
0.00 (0.00%)
Oct 14, 2026, 2:17 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 70.27 million as of October 15, 2026. It is the 30,354th most valuable company in the world and the 837th biggest in Canada. Its market cap has decreased by 61.67% in one year.
Market Cap
70.27M
Enterprise Value
67.79M
Revenue
n/a
Global Rank
Country Rank
#837 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 70.27M, an increase of 648.85%. That is a compound annual growth rate of 6.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 70.27M | -61.18% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 130.19M |
| ME Therapeutics Holdings | 85.09M |
| NurExone Biologic | 57.84M |
| BriaCell Therapeutics | 46.20M |
| MedMira | 45.61M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 41.09M |